Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
144.70B
Market cap144.70B
Price-Earnings ratio
52.22
Price-Earnings ratio52.22
Dividend yield
Dividend yield
Average volume
6.65M
Average volume6.65M
High today
$99.20
High today$99.20
Low today
$97.24
Low today$97.24
Open price
$98.84
Open price$98.84
Volume
9.80M
Volume9.80M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

With a market cap of 144.7B, Boston Scientific(BSX) trades at $97.64. The stock has a price-to-earnings ratio of 52.22.

During the trading session on 2026-01-11, Boston Scientific(BSX) shares reached a daily high of $99.20 and a low of $97.24. At a current price of $97.64, the stock is +0.4% higher than the low and still -1.6% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 9.8M, versus its average volume of 6.65M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

TipRanks 2d
Boston Scientific price target lowered to $112 from $124 at Goldman Sachs

Goldman Sachs analyst David Roman lowered the firm’s price target on Boston Scientific (BSX) to $112 from $124 and keeps a Buy rating on the shares. After a yea...

Simply Wall St 2d
Should Analyst Optimism on Pulsed Field Ablation Shift How Investors View Boston Scientific’s EP Strategy?

Earlier this week, Bank of America Securities reaffirmed a positive analyst rating on Boston Scientific and highlighted progress in its Global Pulsed Field Abla...

Should Analyst Optimism on Pulsed Field Ablation Shift How Investors View Boston Scientific’s EP Strategy?
Nasdaq 3d
Interesting BSX Put And Call Options For February 27th

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options become available today, for the February 27th expiration. At Stock Options Channel , our Yiel...

Interesting BSX Put And Call Options For February 27th

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More BSX News

Nasdaq 3d
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters...

Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
TipRanks 4d
Boston Scientific’s AXIOS™ Gastroenterostomy Trial Paused: What Investors Should Watch

Boston Scientific (BSX) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Study Overview Boston Scientific is running a cli...

TipRanks 4d
Boston Scientific’s RAINBOW Study: What the Hot AXIOS™ Update Means for Investors

Boston Scientific (BSX) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing...

Simply Wall St 4d
Is Boston Scientific Pricing In Too Much Growth After Strong Multi‑Year Share Gains

If you are wondering whether Boston Scientific's current share price reflects its true value, this breakdown will help you see what the market might be pricing...

Is Boston Scientific Pricing In Too Much Growth After Strong Multi‑Year Share Gains
Yahoo Finance 4d
Med tech company Boston Scientific readies for new Austin offices - Yahoo Finance

...

Med tech company Boston Scientific readies for new Austin offices - Yahoo Finance

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.